Medication info
Actogenix Plus Tablet

Actogenix Plus Tablet

Prescription medicationTabletOral
Ingredient · strength
Risedronate Sodium 2.5 Hydrate›40.162mg / 1 tabletCholecalciferol Concentrate Powder›56mg / 1 tablet
Manufacturer / importer
Jeil Pharmaceutical Co., Ltd.
Appearance
Pale orange oval film-coated tablet
Packaging
4 tablets (4 tablets/PTP x 1)
Approval status
Active

MFDS item code 201604922 · Approved 2016.08.11 · Insurance code 645404660

Summary

Main use
Treatment of osteoporosis in men and treatment and prevention of osteoporosis in postmenopausal women
Who takes it
Adults · Children
Adult dose
1. Adults: Administer 1 tablet orally once weekly. 2. Elderly patients: No dose adjustment is necessary in elderly patients (aged 60 years and older), as the bioavailability and pharmacokinetics of this medicine are similar to those in younger people. 4. Patients with renal impairment: No dose adjustment is necessary in patients with creatinine clearance of 30ml/min or higher. This medicine is contraindicated in patients with severe renal impairment and creatinine clearance below 30ml/min. Food interferes with the absorption of this medicine. To ensure adequate absorption, take it as follows. Take it at least 30 minutes before breakfast, or at any time of day at least 2 hours before or after consuming food or beverages. To facilitate passage of this medicine into the stomach and reduce the possibility of esophageal irritation, take it while upright with a sufficient amount of plain water (170 ~ 230ml). Taking this medicine with other beverages, including mineral water, may reduce its absorption. Do not chew or suck this medicine because of the possibility of oropharyngeal ulceration. Patients should also remain upright for at least 30 minutes after taking this medicine. Patients with inadequate calcium and vitamin D intake from food should take supplements. Patients at high risk of vitamin D deficiency (e.g., patients over 70 years of age, residents of nursing homes, and patients with chronic diseases) may need additional vitamin D supplementation. Patients with gastrointestinal malabsorption syndrome may require higher doses of vitamin D supplements, and measurement of 25-hydroxyvitamin D levels should be considered. The recommended daily intake of vitamin D is 400 IU to 800 IU. One weekly dose of this medicine provides a week's supply of vitamin D at 800 IU daily. If a patient forgets to take this medicine on the scheduled day, take it on the day they remember. Resume taking it on the regularly scheduled day for the next dose. Do not take 2 tablets on the same day.
Child dose
3. Children: The safety and efficacy in children and adolescents who are still growing have not been established.

Ingredients

Manufacturer
Jeil Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of osteoporosis in men and treatment and prevention of osteoporosis in postmenopausal women

  • Osteoporosis
View approved original text

This medication is used for the treatment and prevention of osteoporosis in postmenopausal women, as well as for the treatment of osteoporosis in men.

How to take

Adult dose

1. Adults: Administer 1 tablet orally once weekly. 2. Elderly patients: No dose adjustment is necessary in elderly patients (aged 60 years and older), as the bioavailability and pharmacokinetics of this medicine are similar to those in younger people. 4. Patients with renal impairment: No dose adjustment is necessary in patients with creatinine clearance of 30ml/min or higher. This medicine is contraindicated in patients with severe renal impairment and creatinine clearance below 30ml/min. Food interferes with the absorption of this medicine. To ensure adequate absorption, take it as follows. Take it at least 30 minutes before breakfast, or at any time of day at least 2 hours before or after consuming food or beverages. To facilitate passage of this medicine into the stomach and reduce the possibility of esophageal irritation, take it while upright with a sufficient amount of plain water (170 ~ 230ml). Taking this medicine with other beverages, including mineral water, may reduce its absorption. Do not chew or suck this medicine because of the possibility of oropharyngeal ulceration. Patients should also remain upright for at least 30 minutes after taking this medicine. Patients with inadequate calcium and vitamin D intake from food should take supplements. Patients at high risk of vitamin D deficiency (e.g., patients over 70 years of age, residents of nursing homes, and patients with chronic diseases) may need additional vitamin D supplementation. Patients with gastrointestinal malabsorption syndrome may require higher doses of vitamin D supplements, and measurement of 25-hydroxyvitamin D levels should be considered. The recommended daily intake of vitamin D is 400 IU to 800 IU. One weekly dose of this medicine provides a week's supply of vitamin D at 800 IU daily. If a patient forgets to take this medicine on the scheduled day, take it on the day they remember. Resume taking it on the regularly scheduled day for the next dose. Do not take 2 tablets on the same day.

Child dose

3. Children: The safety and efficacy in children and adolescents who are still growing have not been established.

Precautions

This medication may irritate the gastrointestinal mucosa, potentially leading to issues such as esophagitis or esophageal ulcers. It is particularly important to take this medication with a sufficient amount of water and to avoid lying down for a certain time after taking it. If you experience pain or discomfort in the esophagus, you should immediately stop taking the medication and consult a doctor. Patients with esophageal abnormalities, severely impaired kidney function, or specific genetic disorders should not use this medication. It is necessary to intake adequate calcium and vitamin D while taking this medication, and other causes of osteoporosis should also be considered. There may be rare side effects such as jaw osteonecrosis, so attention to oral health is required. This medication may interact with certain drugs, so if you are taking other medications, you must inform your doctor or pharmacist. Pregnant or breastfeeding women should take caution when using this medication and should consult a specialist if necessary. The safety in pediatric patients has not been sufficiently confirmed, so caution should be exercised when using it. In case of overdose, symptoms related to calcium deficiency may occur, so seek medical attention immediately. This medication should be kept out of reach of children and should not be transferred to other containers for safety.

Side effects

  • Esophagitis
  • esophageal ulcer
  • esophageal erosion
  • esophageal obstruction
  • esophageal perforation
  • bleeding
  • gastric ulcer
  • duodenitis
  • duodenal ulcer
  • infection
Show 110 more
  • lumbago
  • pain
  • abdominal pain
  • throat pain
  • weakness
  • chest pain
  • hernia
  • hypertension
  • cardiovascular disease
  • angina
  • nausea
  • diarrhea
  • bloating
  • gastritis
  • gastrointestinal diseases
  • rectal diseases
  • dental diseases
  • petechiae
  • anemia
  • arthralgia
  • joint abnormalities
  • myalgia
  • bone pain
  • bone abnormalities
  • leg cramps
  • synovitis
  • tendon abnormalities
  • depression
  • dizziness
  • insomnia
  • anxiety
  • neuralgia
  • vertigo
  • tension
  • sensory abnormalities
  • pharyngitis
  • rhinitis
  • dyspnea
  • pneumonia
  • rash
  • itching
  • skin cancer
  • cataract
  • conjunctivitis
  • otitis media
  • urinary tract infection
  • cystitis
  • injuries from accidents
  • influenza-like illness
  • headache
  • overdose
  • allergic reactions
  • syncope
  • vasodilation
  • constipation
  • dyspepsia
  • nausea
  • gastroenteritis
  • colitis
  • vomiting
  • thirst
  • peripheral edema
  • traumatic fractures
  • myopathy
  • arthritis
  • bronchitis
  • sinusitis
  • increased cough
  • fever
  • falls
  • dizziness
  • bronchitis
  • influenza
  • nasopharyngitis
  • upper respiratory tract infection
  • osteoarthritis
  • limb pain
  • muscle rigidity
  • neck pain
  • weakness
  • hypercholesterolemia
  • uveitis
  • iritis
  • osteonecrosis of the jaw
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • angioedema
  • blisters
  • skin reactions
  • loss of appetite
  • chest discomfort
  • palpitations
  • increased sweating
  • facial flushing
  • burning sensation
  • kidney stones
  • belching
  • hematuria
  • fever
  • fatty liver
  • increased serum alkaline phosphatase
  • facial edema
  • hair loss
  • altered sense of smell
  • hypocalcemia
  • hypercalcemia
  • hypercalciuria
  • polyuria
  • weakness
  • drowsiness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. The ideal storage temperature is between 1°C and 30°C to safely maintain its effectiveness.

Appearance and packaging

Appearance

Pale orange oval film-coated tablet

Package unit

4 tablets (4 tablets/PTP x 1)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.